Salim Dhanji
Vermogen: 7 M $ op 31-05-2026
Vermogen: 7 M $ op 31-05-2026
Salim Zulifkar Dhanji is President, Chief Executive Officer & Director at ME Therapeutics Holdings, Inc. since 2023.
Dr. Dhanji is President at Perceptive Property Development since 2013.
Formerly, Dr. Dhanji was Director-Preclinical Research at Qu Biologics, Inc. from 2009 to 2014.
Education includes an undergraduate degree (2001) and a doctorate (2006) from the University of British Columbia.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-03-2026 | 4.175.143 ( 13,89% ) | 7 M $ | 31-05-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| ME THERAPEUTICS HOLDINGS INC. | Algemeen Directeur | 09-03-2023 |
| Bedrijven | Functie | Einde |
|---|---|---|
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer | Corporate Officer/Principal | 01-01-2014 |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
University of British Columbia
University of British Columbia Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Qu Biologics, Inc.
Qu Biologics, Inc. BiotechnologyHealth Technology Develops site specific immunomodulators that aim to restore the body's innate immune system to treat cancer | Health Technology |
ME Therapeutics Holdings, Inc.
ME Therapeutics Holdings, Inc. BiotechnologyHealth Technology Provides biotechnology and pharmaceutical services | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau